TARA · Protara Therapeutics, Inc.

$3.85 -0.05 (-1.28%) At close · Aug 21

Market Cap

$229.29M

59.10M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2024-03-31 YTD	$76,000	—	—	10-Q, filed 2024-05-02
2023-12-31	$91,000	—	—	10-K, filed 2024-03-13
2022-12-31	$90,000	—	—	10-K, filed 2024-03-13
2021-12-31	$228,000	—	—	10-K, filed 2023-03-08

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2024-03-31	$76,000	—	—	10-Q, filed 2024-05-02
2023-12-31	$0 Δ	—	—	10-K, filed 2024-03-13
2023-09-30	$27,000 Δ	—	—	10-Q, filed 2023-11-03
2023-06-30	$0 Δ	—	—	10-Q, filed 2023-08-03
2023-03-31	$64,000	—	—	10-Q, filed 2024-05-02
2022-12-31	$0 Δ	—	—	10-K, filed 2024-03-13
2022-09-30	$18,000 Δ	—	—	10-Q, filed 2023-11-03
2022-06-30	$0 Δ	—	—	10-Q, filed 2023-08-03
2022-03-31	$72,000	—	—	10-Q, filed 2023-05-04
2021-12-31	$0 Δ	—	—	10-K, filed 2023-03-08
2021-09-30	$0 Δ	—	—	10-Q, filed 2022-11-03
2021-06-30	$0 Δ	—	—	10-Q, filed 2022-08-09

Key facts CIK 1359931 CUSIP 74365U107 13F (30d) 112 filings 112 filers Visit website Investor relations